Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$55,237,244
+$6,709,788 QoQ
Shares Held
219,509
-1.6% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#345
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BRADLEY FOSTER & SARGENT INC/CT holds $254,262,538 across 12 Drug Manufacturers - General names. ABBV ranks #2 (21.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
333,906 | $84,802,106 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
219,509 | $55,237,244 | |
| 3 | LLY |
ELI LILLY & Co
|
35,186 | $42,203,147 | |
| 4 | MRK |
Merck & Co., Inc.
|
287,164 | $36,900,574 | |
| 5 | PFE |
Pfizer Inc
|
678,377 | $16,335,318 | |
| 6 | AMGN |
Amgen Inc
|
13,889 | $5,029,484 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
38,875 | $4,911,467 | |
| 8 | NVS |
Novartis AG
|
17,635 | $2,763,757 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,237,244 | 219,509 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $48,527,456 | 223,125 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $52,096,862 | 228,005 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $53,521,860 | 231,156 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $43,196,743 | 232,716 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $48,668,143 | 232,284 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $41,812,454 | 235,298 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $47,074,097 | 238,374 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $41,904,394 | 244,312 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $44,710,466 | 245,527 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $39,096,296 | 252,283 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $38,387,570 | 257,531 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $34,697,151 | 257,531 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $41,084,629 | 257,794 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $42,168,897 | 260,930 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $35,043,707 | 261,111 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $39,356,759 | 256,965 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $41,816,760 | 257,953 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $33,968,339 | 250,874 | Shares | Sole | 2022-03-11 | |
| 2021-09-30 | $23,917,367 | 221,724 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $24,054,722 | 213,554 | Shares | Sole | 2021-08-19 | |
| 2021-03-31 | $21,140,668 | 195,349 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $18,990,944 | 177,237 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $14,919,905 | 170,338 | Shares | Sole | 2020-10-26 | |
| 2020-03-31 | $11,648,308 | 152,885 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||